The distinct histopathological features of MMR-deficient endometrial carcinomas not only have diagnostic value but may also have prognostic implications, as these tumors have been associated with improved clinical outcomes compared to their MMR-proficient counterparts [27,28]. This evidence concerns the gene MRC1 and endometrial carcinoma.